<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35619573</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1976-2437</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Yonsei medical journal</Title><ISOAbbreviation>Yonsei Med J</ISOAbbreviation></Journal><ArticleTitle>One Year Follow-Up of COVID-19 Related Symptoms and Patient Quality of Life: A Prospective Cohort Study.</ArticleTitle><Pagination><StartPage>499</StartPage><EndPage>510</EndPage><MedlinePgn>499-510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3349/ymj.2022.63.6.499</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Globally, concerns have grown regarding the long-term effects of novel coronavirus disease (COVID-19) infection. Therefore, we evaluated the long-term course of persistent symptoms and patient quality of life.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This prospective cohort study was conducted at a single tertiary university hospital from August 31, 2020 to March 29, 2021 with adult patients followed at 6 and 12 months after acute COVID-19 symptom onset or diagnosis. Clinical characteristics, self-reported symptoms, EuroQol 5 dimension 5 level (EQ5D-5L) index scores, Korean version of the Patient Health Questionnaire-9 (PHQ-9), Korean version of the Posttraumatic Stress Disorder Checklist-5 (PCL-5-K), and Generalized Anxiety Disorder-7 (GAD-7) were investigated. Symptom persistent or non-persistent groups were defined according to persistency of COVID-19 related symptoms or signs after acute COVID-19 infection, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of all 235 patients, 170 (64.6%) patients were eligible for analysis. The median age was 51 (interquartile range, 37-61) years old, and 102 patients were female (60.0%). After 12 months from acute COVID-19 infection, in total, 83 (48.8%) patients still suffered from COVID-19-related symptoms. The most common symptoms included amnesia (24.1%), insomnia (14.7%), fatigue (13.5%), and anxiety (12.9%). Among the five EQ5D-5L categories, the average value of anxiety or depression was the most predominant. PHQ-9 and PCL-5-K scores were statistically higher in the COVID-19-related symptom persistent group than the non-persistent group (<i>p</i>=0.001). However, GAD-7 scores showed no statistical differences between the two groups (<i>p</i>=0.051).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neuropsychiatric symptoms were the major COVID-19-related symptoms after 12 months from acute COVID-19 infection, reducing quality of life.</AbstractText><CopyrightInformation>&#xa9; Copyright: Yonsei University College of Medicine 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yoonjung</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7454-4014</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Shin-Woo</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-3755-8249</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea. ksw2kms@knu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Hyun-Ha</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0002-9405-2121</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Ki Tae</ForeName><Initials>KT</Initials><Identifier Source="ORCID">0000-0003-4666-0672</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Soyoon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3618-174X</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sohyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0206-7108</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020-ER5334-00</GrantID><Agency>Korea Centers for Disease Control and Prevention</Agency><Country>Republic of Korea</Country></Grant><Grant><GrantID>2021-ER1901-00</GrantID><Agency>Korea Centers for Disease Control and Prevention</Agency><Country>Republic of Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Yonsei Med J</MedlineTA><NlmUniqueID>0414003</NlmUniqueID><ISSNLinking>0513-5796</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">life quality</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-term consequences</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword></KeywordList><CoiStatement>The authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>27</Day><Hour>2</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35619573</ArticleId><ArticleId IdType="pmc">PMC9171672</ArticleId><ArticleId IdType="doi">10.3349/ymj.2022.63.6.499</ArticleId><ArticleId IdType="pii">63.499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, et al. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect. 2021;83:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) 2021;8:653516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D, Vasto S, Scalisi L, Cottone S, Cambula G, Rizzo M, et al. Post-acute COVID-19 neurological syndrome: a new medical challenge. J Clin Med. 2021;10:1947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124354</ArticleId><ArticleId IdType="pubmed">34062770</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Green J, Santillana M, Lazer D, Ognyanova K, Simonson M, et al. Persistence of symptoms up to 10 months following acute COVID-19 illness. [accessed 2021 August 30];medRxiv [Preprint] 2021 doi: 10.1101/2021.03.07.21253072. Available at:</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.07.21253072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim SW, Chang HH, Kwon KT, Bae S, Hwang S. Significance and associated factors of long-term sequelae in patients after acute COVID-19 infection in Korea. Infect Chemother. 2021;53:463&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511373</ArticleId><ArticleId IdType="pubmed">34405592</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KH, Kim AR, Yang MA, Lim SJ, Park JH. Impact of the COVID-19 pandemic on the lifestyle, mental health, and quality of life of adults in South Korea. PLoS One. 2021;16:e0247970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7909697</ArticleId><ArticleId IdType="pubmed">33635897</ArticleId></ArticleIdList></Reference><Reference><Citation>ISARIC. Long term follow-up protocol and study [Internet]  [accessed on 2021 August 15].  Available at:  https://isaric.org/research/covid-19-clinical-research-resources/covid-19-long-term-follow-up-study/</Citation></Reference><Reference><Citation>Kim SW, Kim SM, Kim YK, Kim JY, Lee YM, Kim BO, et al. Clinical characteristics and outcomes of COVID-19 cohort patients in Daegu metropolitan city outbreak in 2020. J Korean Med Sci. 2021;36:e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781854</ArticleId><ArticleId IdType="pubmed">33398946</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]  [Accessed April 21, 2021].  Available at:  https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. 2022;74:1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank A, Tzortzini A, Kling E, Schmid C, Claus R, L&#xf6;ll E, et al. One year after mild COVID-19: the majority of patients maintain specific immunity, but one in four still suffer from long-term symptoms. J Clin Med. 2021;10:3305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347559</ArticleId><ArticleId IdType="pubmed">34362088</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker HA, Safavynia SA, Evered LA. The &#x2018;third wave&#x2019;: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth. 2021;126:44&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577658</ArticleId><ArticleId IdType="pubmed">33187638</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzzo D, Picone P, Caruana L, Vasto S, Barera A, Caruso C, et al. Inflammatory mediators as biomarkers in brain disorders. Inflammation. 2014;37:639&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">24292800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: at the crossroad between aging and neurodegeneration. Mov Disord. 2020;35:716&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262312</ArticleId><ArticleId IdType="pubmed">32291797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94:809&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">32229625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35:e174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211515</ArticleId><ArticleId IdType="pubmed">32383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xc1;, Mata-V&#xe1;zquez E, Mart&#xed;n-Toledano M, L&#xf3;pez-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10:2945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2021;6:116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142:68&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136:1342&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelen MM, Vandenbriele C, Balthazar T, Claeys E, Gunst J, Guler I, et al. Venous thromboembolism in patients discharged after COVID-19 hospitalization. Semin Thromb Hemost. 2021;47:362&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">33893631</ArticleId></ArticleIdList></Reference><Reference><Citation>Garratt AM, Ghanima W, Einvik G, Stavem K. Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions. J Infect. 2021;82:186&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834148</ArticleId><ArticleId IdType="pubmed">33434590</ArticleId></ArticleIdList></Reference><Reference><Citation>Todt BC, Szlejf C, Duim E, Linhares AOM, Kogiso D, Varela G, et al. Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge. Respir Med. 2021;184:106453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116128</ArticleId><ArticleId IdType="pubmed">34010740</ArticleId></ArticleIdList></Reference><Reference><Citation>Walle-Hansen MM, Ranhoff AH, Mellings&#xe6;ter M, Wang-Hansen MS, Myrstad M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21:199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983098</ArticleId><ArticleId IdType="pubmed">33752614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung SJ, Jun JY. Mental health and psychological intervention amid COVID-19 outbreak: perspectives from South Korea. Yonsei Med J. 2020;61:271&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105405</ArticleId><ArticleId IdType="pubmed">32233168</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake JH, Wesselius S, van Genderen ME, van Bommel J, Boxmade Klerk B, Wils EJ. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: a single-center, observational study. PLoS One. 2021;16:e0255774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357130</ArticleId><ArticleId IdType="pubmed">34379644</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>